Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
BARK
BARK
$91.4M
| $1.89M | ﹤0.01% |
63,555
-36,544
| -37% | -$1.22M |
|
2102
The Honest Company
HNST
$519M
| $1.89M | ﹤0.01% |
628,300
+65,000
| +12% | +$203K |
|
|
IBDQ
2103
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $1.89M | ﹤0.01% |
+77,717
| New | +$1.88M |
|
|
FSP
2104
Franklin Street Properties
FSP
$50.8M
| $1.89M | ﹤0.01% |
691,485
-248,452
| -26% | -$688K |
|
2105
iShares MSCI Turkey ETF
TUR
$222M
| $1.89M | ﹤0.01% |
51,000
+37,000
| +264% | +$1.13M |
|
2106
Byline Bancorp
BY
$1.78B
| $1.89M | ﹤0.01% |
82,071
-4,100
| -5% | -$91.9K |
|
2107
Core & Main
CNM
$8.61B
| $1.88M | ﹤0.01% |
+97,400
| New | +$2.08M |
|
2108
Precision BioSciences
DTIL
$205M
| $1.88M | ﹤0.01% |
52,691
-19,731
| -27% | -$780K |
|
2109
LCNB Corp
LCNB
$283M
| $1.87M | ﹤0.01% |
104,116
-12,681
| -11% | -$222K |
|
2110
AvePoint
AVPT
$2.85B
| $1.87M | ﹤0.01% |
455,200
+54,900
| +14% | +$235K |
|
2111
Dimensional US Core Equity Market ETF
DFAU
$12.9B
| $1.87M | ﹤0.01% |
69,200
+34,400
| +99% | +$935K |
|
|
NTCO
2112
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $1.87M | ﹤0.01% |
431,737
-132,900
| -24% | -$644K |
|
2113
Oric Pharmaceuticals
ORIC
$1.44B
| $1.87M | ﹤0.01% |
316,800
-84,600
| -21% | -$286K |
|
2114
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.4B
| $1.86M | ﹤0.01% |
4,200
+2,300
| +121% | +$1.02M |
|
|
WOW
2115
DELISTED
WideOpenWest
WOW
| $1.86M | ﹤0.01% |
+204,100
| New | +$2.31M |
|
2116
Innospec
IOSP
$2.31B
| $1.85M | ﹤0.01% |
18,000
-12,900
| -42% | -$1.31M |
|
2117
Ocugen
OCGN
$458M
| $1.85M | ﹤0.01% |
+1,422,856
| New | +$2.22M |
|
2118
Quest Resource Holding
QRHC
$33.7M
| $1.85M | ﹤0.01% |
302,492
-11,900
| -4% | -$88.7K |
|
2119
Solid Power
SLDP
$552M
| $1.85M | ﹤0.01% |
+727,400
| New | +$3.11M |
|
|
IAS
2120
DELISTED
Integral Ad Science
IAS
| $1.85M | ﹤0.01% |
210,080
-142,620
| -40% | -$1.21M |
|
2121
Rambus
RMBS
$10.9B
| $1.84M | ﹤0.01% |
51,500
-4,600
| -8% | -$156K |
|
2122
American Water Works
AWK
$27.1B
| $1.84M | ﹤0.01% |
12,100
-121,400
| -91% | -$17.5M |
|
|
CTLP
2123
DELISTED
Cantaloupe
CTLP
| $1.84M | ﹤0.01% |
423,635
+230,335
| +119% | +$817K |
|
|
PTVE
2124
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.84M | ﹤0.01% |
161,800
-53,500
| -25% | -$584K |
|
|
ABCM
2125
DELISTED
Abcam PLC
ABCM
| $1.84M | ﹤0.01% |
118,049
+28,000
| +31% | +$437K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.